176 related articles for article (PubMed ID: 30448281)
1. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
[TBL] [Abstract][Full Text] [Related]
2. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
Miida T; Yamada T; Seino U; Ito M; Fueki Y; Takahashi A; Kosuge K; Soda S; Hanyu O; Obayashi K; Miyazaki O; Okada M
Biochim Biophys Acta; 2006 Apr; 1761(4):424-33. PubMed ID: 16651021
[TBL] [Abstract][Full Text] [Related]
4. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
Ma QL; Galasko DR; Ringman JM; Vinters HV; Edland SD; Pomakian J; Ubeda OJ; Rosario ER; Teter B; Frautschy SA; Cole GM
Arch Neurol; 2009 Apr; 66(4):448-57. PubMed ID: 19364929
[TBL] [Abstract][Full Text] [Related]
5. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U
Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease.
Ikeuchi T; Hirayama S; Miida T; Fukamachi I; Tokutake T; Ebinuma H; Takubo K; Kaneko H; Kasuga K; Kakita A; Takahashi H; Bujo H; Saito Y; Nishizawa M
Dement Geriatr Cogn Disord; 2010; 30(1):28-32. PubMed ID: 20689279
[TBL] [Abstract][Full Text] [Related]
9. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments.
Offe K; Dodson SE; Shoemaker JT; Fritz JJ; Gearing M; Levey AI; Lah JJ
J Neurosci; 2006 Feb; 26(5):1596-603. PubMed ID: 16452683
[TBL] [Abstract][Full Text] [Related]
10. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
11. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
12. Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.
Minta K; Brinkmalm G; Janelidze S; Sjödin S; Portelius E; Stomrud E; Zetterberg H; Blennow K; Hansson O; Andreasson U
Alzheimers Res Ther; 2020 Feb; 12(1):19. PubMed ID: 32054532
[TBL] [Abstract][Full Text] [Related]
13. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
[TBL] [Abstract][Full Text] [Related]
15. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro.
Taira K; Bujo H; Hirayama S; Yamazaki H; Kanaki T; Takahashi K; Ishii I; Miida T; Schneider WJ; Saito Y
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1501-6. PubMed ID: 11557679
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
17. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
Mulder M; Terwel D
Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
[TBL] [Abstract][Full Text] [Related]
18. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
[TBL] [Abstract][Full Text] [Related]
20. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]